Catherine Illingworth is the Founder & CEO of Kylix Bio, advancing forgotten gene therapies for children with rare genetic diseases. Catherine’s background is in humanities academia: she holds an MA from Yale, an MA from UCLA, and a BA from Pepperdine University. She was in the final year of her PhD at UCLA, writing a dissertation on Dante and Augustine, when her four-year-old’s diagnosis compelled her to withdraw and turn her attention to rare disease. She has three young children.
linkedin